These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 150320)

  • 21. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.
    Cornelissen J; Kirtland S; Lim E; Goddard M; Bellm S; Sheridan K; Large S; Vuylsteke A
    Thromb Haemost; 2006 Mar; 95(3):476-82. PubMed ID: 16525576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of increasing doses of aspirin on platelet aggregation among stroke patients.
    Gan R; Teleg RA; Florento L; Bitanga ES
    Cerebrovasc Dis; 2002; 14(3-4):252-5. PubMed ID: 12403959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aspirin-like defect - a hereditary thrombocytopathy due to impaired release of platelet adenosine diphosphate].
    Elezović I; Mijović A; Rolović Z
    Bilt Hematol Transfuz; 1979; 7(2-3):165-74. PubMed ID: 263623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells.
    Marcus AJ; Safier LB; Hajjar KA; Ullman HL; Islam N; Broekman MJ; Eiroa AM
    J Clin Invest; 1991 Nov; 88(5):1690-6. PubMed ID: 1939654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation and the ouabain-insensitive ATPase. Ecto-ATPase, reflection of membrane integrity.
    Wang TY; Hussey CV; Sasse EA; Hause LL
    Am J Clin Pathol; 1977 Jun; 67(6):528-32. PubMed ID: 141204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
    Clowes AW; Karnovsky MJ
    Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP.
    Evans PM
    Cytobios; 1978; 23(90):101-8. PubMed ID: 158489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
    Terres W; Schuster O; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation induced by antilymphocyte serum. I. Differences between washed and unwashed platelets.
    Hussey CV; Wang TY; Garancis JC; Fobian JE
    Am J Clin Pathol; 1975 Nov; 64(5):580-90. PubMed ID: 811109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of U46619 induced human platelet aggregation by aspirin.
    Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
    Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme activities on the platelet surface in relation to the action of adenosine diphosphate.
    Mustard JF; Packham MA; Perry DW; Guccione MA; Kinlough-Rathbone RL
    Ciba Found Symp; 1975; 35():47-75. PubMed ID: 179770
    [No Abstract]   [Full Text] [Related]  

  • 39. A circulating inhibitor of platelet aggregation in Bartter's syndrome.
    O'Reagan SO; Rivard GE; Mongeau JG; Robitaille PO
    Pediatrics; 1979 Dec; 64(6):939-41. PubMed ID: 117424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.